Kraig Biocraft Laboratories Inc (KBLB)

[Deannie]

“if any shareholder has a 10 cent or higher average cost per share, they would have to be comatose to have not bought and averaged down at .03...”

Many would argue (myself included) that buying more KBLB to average down would be throwing out good money after bad, or “comatose” as you put it. There’s a reason (several, actually) the stock is only at four cents and it could be argued the reasons it’s there should preclude all but the “comatose” from adding to their positions.